
    
      The investigators' objective is to assess patient decision-making, anxiety and patient
      satisfaction with recommendations made by an oncologist before and after the BCI test results
      are known. In addition, a chart review will be performed annually for five years to assess
      disease status and medications. Specifically, if extended endocrine therapy was recommended
      the chart review will record if participants are taking the medication and, if not, why the
      treatment was discontinued.
    
  